Excellence in imaging endpoints for CNS trials

  • 58

    Clinical trials
  • 12,987

  • 2,900


ICON has significant experience in all major central nervous system indications and imaging modalities. We provide personal, one-on-one interaction and consulting on the critical uses of imaging in your trials. We have one of the most experienced teams in the industry with a wide range of therapeutic expertise. Our highly trained neuroradiologists, imaging scientists and radiologists possess significant experience in CT, PET-CT, simultaneous PET-MRI, fNIRS, fMRI, and MRI.

We have managed clinical trial imaging studies for a variety of central nervous system diseases including Alzheimer’s disease, Glioblastoma Multiforme, Multiple Sclerosis, Parkinson’s disease, Schizophrenia and Stroke. Over 90% of ICON's imaging’s core laboratory staff are modality-specific actively certified technologists, ensuring that QC and pre-processing tasks are handled by imaging professionals.

ICON provides leading image management, the fastest blinded read setup in the industry, 21 CFR Part 11 compliant technology, and a complete image based knowledge management system all designed to empower the sponsor with access to critical information anywhere, anytime.

Delivering benefits to your CNS trial:

- ICON's medical imaging experts deliver quality end-to-end scientific and imaging management solutions, providing strategic advice on the design, development and imaging acquisition parameters in your protocol that meet regulatory requirements.

- In-house board-certified nuclear medicine physician, and diagnostic and interventional neuroradiologist

- In-house neuroscience/neuroimaging trained scientists

- Certified imaging specialists with significant processing experience in CT, MR, PET

- Global network of trained neurologists and radiologists for both remote and monitored reads in all modalities

- Biomedical engineers

– Biostatistician

– Data management team

– Medical writers